Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases

Critical Reviews in Oncology/Hematology

Volumn 73, Issue 3, 2010, Pages 246-254

  Cutuli, B ^a   Le Nir, C Cohen Solal ^b   Serin, D ^c   Kirova, Y ^d   Gaci, Z ^e   Lemanski, C ^f   De Lafontan, B ^g   Zoubir, M ^h   Maingon, P ⁱ   Mignotte, H ^j   Lara, C Tunon de ^k   Edeline, J ^l   Penault Llorca, F ^m   Romestaing, P ⁿ   Delva, C ^o   Comet, B ^p   Belkacemi, Y ^q  

^a Radiation Oncology Department   (France)

^b CENTRE RENÉ HUGUENIN   (France)

^c INSTITUT SAINTE CATHERINE   (France)

^d INSTITUT CURIE   (France)

^e Clinique Catherine de Sienne   (France)

^f CENTRE VAL D AURELLE   (France)

^g INSTITUT CLAUDIUS REGAUD   (France)

^h INSTITUT GUSTAVE ROUSSY   (France)

ⁱ CENTRE GEORGES FRANÇOIS LECLERC   (France)

^j CENTRE LÉON BÉRARD   (France)

^k INSTITUT BERGONIÉ   (France)

^l CENTRE EUGÈNE MARQUIS   (France)

^m CENTRE JEAN PERRIN   (France)

ⁿ CENTRE HOSPITALIER LYON SUD   (France)

^o Sylia Stat   (France)

^p CENTRE OSCAR LAMBRET   (France)

^q HENRI MONDOR HOSPITAL   (France)

more..

Author keywords

Aromatase inhibitors; Chemotherapy; Local recurrence; Male breast cancer; Mastectomy; Metastases; Prognostic factors; Radiotherapy; Survival; Tamoxifen

Indexed keywords

ANTHRACYCLINE; AROMATASE INHIBITOR; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; TAMOXIFEN;

ADULT; AGED; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CAUSE OF DEATH; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; METASTASIS; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PROGNOSIS; REVIEW; RISK FACTOR; SURVIVAL RATE; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; BREAST NEOPLASMS, MALE; COHORT STUDIES; HUMANS; MALE; MASTECTOMY; MIDDLE AGED; PROGNOSIS; TAMOXIFEN; YOUNG ADULT;

EID: 75049085134     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2009.04.002     Document Type: Review

References (66)

1. Crichlow R.W., and Galt S.W. Male breast cancer. Surg Clin North Am 70 (1990) 1165-1170
2. Donegan W.L., and Redlich P.N. Breast cancer in men. Surg Clin North Am 76 (1996) 343-363
3. Fentiman I.S., Fourquet A., and Hortobagyi G. Male breast cancer. Lancet 367 (2006) 595-604
4. Gennari R., Curigliano G., Jereczec-Fossa B., et al. Male breast cancer: a special therapeutic problem. Anything new?. Int J Oncol (2004) 663-670
5. Cutuli B. Strategies in treating male breast cancer. Expert Opin Pharmacother 8 (2007) 193-202
6. Goss P.E., Reid C., Pintilie M., et al. Male breast carcinoma. A review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer 85 (1999) 629-639
7. Guinee V.F., Olsson H., Moller T., et al. The prognosis of breast cancer in males. A report of 335 cases. Cancer 71 (1993) 154-161
8. Ribeiro G.G., Swindell R., Harris M., et al. A review of the management of the male breast carcinoma based on an analysis of 420 treated cases. The Breast 5 (1996) 141-146
9. Cutuli B., Lacroze M., Dilhuydy J.M., et al. Male breast cancer. Results of the treatments and prognostic factors in 397 cases. Eur J Cancer 31A (1995) 1960-1964
10. Scheike O. Male breast cancer. 5. Clinical manifestations in 257 cases in Denmark. Br J Cancer 28 (1973) 552-561
11. Cutuli B., Cohen-Solal Le Nir C., Serin D., et al. Impact of early diagnosis and adjuvant treatments: the male breast cancer (MBC) model. Analysis of 983 cases. Breast Cancer Res Treat 5 Suppl 1 (2007) 222
12. Nahleh Z., Srikantiah R., Safa M., Jazieh A.R., Muhleman A., and Komrokji R. Male breast cancer in the veterans affairs population. A comparative analysis. Cancer 109 (2007) 1471-1477
13. Giordano S.H., Perkins G.H., Broglio K., et al. Adjuvant systemic therapy for male breast carcinoma. Cancer 104 (2005) 2359-2364
14. Macdonald G., Paltiel C., Olivotto I.A., and Tyldesley S. A comparative analysis of radiotherapy use and patient outcome in males and females with breast cancer. Ann Oncol 16 (2005) 1442-1448
15. Donegan W.L., Redlich P.N., Lang P.J., and Gall M.T. Carcinoma of the breast in males: a multi institutional survey. Cancer 83 (1998) 498-509
16. Salvadori B., Saccozzi R., Manzari A., et al. Prognosis of breast cancer in males: an analysis of 170 cases. Eur J Cancer 30A (1994) 930-935
17. Hill A., Yagmour Y., Tran K.N., et al. Localized male breast carcinoma and family history. An analysis of 142 patients. Cancer 86 (1999) 821-825
18. Cutuli B., Cottu P.H., Guastalla J.P., Mechin H., Costa A., and Jourdan R. A French national survey on infiltrating breast cancer: analysis of clinico-pathological features and treatment modalities in 1159 patients. Breast Cancer Res Treat 95 (2006) 55-64
19. Burga A.M., Fadare O., Lininger R.A., and Tavassoli F.A. Invasive carcinomas of the male breast: a morphologic study of the distribution of histologic subtypes and metastatic patterns in 778 cases. Vinchows Arch 449 (2006) 507-512
20. Hultborn R., Friberg S., and Hultborn K.A. Male breast carcinoma. A study of the total material reported to the Swedish cancer registry 1958-1967 with respect to clinical and histopathological parameters. Acta Oncol 26 (1987) 241-256
21. Stalsberg H., Thomas D.B., Rosenblatt K.A., et al. Histologic types and hormone receptors in breast cancer in United States men: a population-based study in 282 men. Cancer Causes Control 4 (1993) 143-151
22. Murphy C.E., Carder P.J., Landsdown M.R., and Speirs V. Steroid hormone receptor expression in male breast cancer. Eur J Surg Oncol 32 (2006) 44-47
23. Stierer M., Rosen H., Weitensfelder W., et al. Male breast cancer: Austrian experience. World J Surg 19 (1995) 687-693
24. Olsson H. Estrogen receptors content in malignant breast tumors in men. A review. J Mammary Gland Biol Neoplasia 5 (2000) 283-287
25. Borgen P.I., Wong G.Y., Vlamis V., et al. Current management of male breast cancer. A review of 104 cases. Ann Surg 215 (1992) 451-459
26. Truong P.T., Berthelet E., Lee J., Kader H.A., and Olivotto I.A. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer 103 (2005) 2006-2014
27. Vinh-Hung V., Verschraegen C., and Promish D.I. Ratio of involved nodes in early breast cancer. Breast Cancer Res 6 (2004) R 680-R 688
28. Goyal A., Horgan K., Kissin M., et al. Sentinel lymph node biopsy in male breast cancer patients. Eur J Surg Oncol 30 (2004) 480-483
29. Port E.R., Fey J.V., Cody III H.S., and Borgen P.I. Sentinel lymph node biopsy in patients with male breast carcinoma. Cancer 91 (2001) 319-323
30. Boughey J.C., Bedrosian I., Meric-Bernstam F., et al. Comparative analysis of sentinel lymph node operation in male and female breast cancer patients. J Am Coll Surg 203 (2006) 475-480
31. Gentilini O., Chagas E., Zurrida S., et al. Sentinel lymph node biopsy in male patients with early breast cancer. The Oncologist 12 (2007) 512-515
32. Gennari R., Scelsi M., Greco M., and Costa A. Complete nodal staging in male breast cancer (biopsy of axillary and internal mammary sentinel node). J Exp Clin Cancer Res 23 (2004) 163-165
33. Wallgren A., Bonetti M., Gelber R.D., et al. Risk factors for locoregional recurrence among breast cancer patients; results from International Breast Cancer Study Group Trials I through VII. J Clin Oncol 21 (2003) 1205-1213
34. Kurtz J. The curative role of radiotherapy in the treatment of operable breast cancer. Eur J Cancer 38 (2002) 1961-1974
35. Recht A., and Edge S.B. Evidence-based indications for postmastectomy irradiation. Surg Clin N Am 83 (2003) 995-1013
36. Pierce L.J. The use of radiotherapy after mastectomy: a review of the literature. J Clin Oncol 23 (2005) 1706-1717
37. Truong P.T., Woodward W.A., and Buchholz T.A. Optimizing locoregional control and survival for women with breast cancer: a review of current developments in post mastectomy radiotherapy. Expert Rev Anticancer Ther 6 (2006) 205-216
38. Nielsen H.M., Overgaard M., Grau C., Jensen A.R., and Overgaard J. Study of failure pattern among high-risk breast cancer patients with or without post mastectomy radiotherapy in addition to systemic therapy: long term results from the Danish Breast Cancer Cooperative Group DBCG 82b and c randomized studies. J Clin Oncol 24 (2006) 2268-2275
39. Ragaz J., Olivotto I.A., Spinelli J.J., et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97 (2005) 116-126
40. Early Breast Cancer Trialist Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet 365 (2005) 2087-2106
41. Erlichman C., Murphy K.C., and Elhakim T. Male breast cancer: a 13 year review of 89 patients. J Clin Oncol 2 (1984) 903-909
42. El Omari-Alaoui H., Lahdiri I., Nejjar I., et al. Male breast cancer. A report of 71 cases. Cancer Radiother 6 (2002) 349-351
43. Chakravarthy A., and Kim C.R. Post mastectomy radiation in male breast cancer. Radiother Oncol 65 (2002) 99-103
44. Izquierdo M.A., Alonso C., De Andres L., et al. Male breast cancer. Report of a series of 50 cases. Acta Oncol 33 (1994) 767-771
45. Schuchardt U., Seegenschmiedt M.H., Kirschner M.J., Renner H., and Sauer R. Adjuvant radiotherapy for breast carcinoma in men: a 20-year clinical experience. Ann J Clin Oncol 19 (1996) 330-336
46. Stranzl H., Mayer R., Quehenberger F., et al. Adjuvant radiotherapy in male breast cancer. Radiother Oncol 53 (1999) 29-35
47. Zabel A., Milker-Zabel S., Zuna I., Wannenmacher M., and Debus J. External beam radiotherapy in the treatment of male breast carcinoma: patterns of failure in a simple institute experience. Tumori 91 (2005) 151-155
48. Mauriac L., Luporsi E., Cutuli B., et al. Summary version of standard options and recommendations for non-metastatic breast cancer. Br J Cancer 89 Suppl 1 (2003) 517-531
49. NCCN (National Comprehensive Cancer Network) Breast Cancer Guidelines. http://www.nccn.org.
50. Iredale R., Brain K., Williams B., France E., and Gray J. The experiences of men with breast cancer in the United Kingdom. Eur J Cancer 42 (2006) 334-341
51. Bagley C.S., Wesley M.N., Young R.C., and Lippman M.E. Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol 10 (1987) 55-60
52. Patel H.Z., Buzdar A.V., and Hortobagy G.N. Role of adjuvant chemotherapy in male breast cancer. Cancer 64 (1989) 1583-1585
53. Yildirim E., and Berberoglu U. Male breast cancer: a 22-year experience. Eur J Surg Oncol 24 (1998) 548-552
54. Walshe J.M., Berman A.W., Vatas U., et al. A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up. Breast Cancer Res Treat 103 (2007) 177-183
55. Giordano S.H., Duan Z., Kuo Y.F., Hortobagyi G.N., and Goodwin J.S. Use and outcome of adjuvant chemotherapy in older women with breast cancer. J Clin Oncol 24 (2006) 2750-2756
56. Extermann M., Balducci L., and Lyman G.H. What threshold for adjuvant therapy in older breast cancer patients?. J Clin Oncol 18 (2000) 1709-1717
57. Early Breast Cancer Trialist Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 365 (2005) 1687-1717
58. Dimitrov N.V., Colucci P., and Nagpa L. Some aspects of the endocrine profile and management of hormone-dependent male breast cancer. The Oncologist 12 (2007) 798-807
59. Cutuli B, De Lafontan B, Vitali E, et al. Breast conserving treatment (BCT) for stage I-II breast cancer in elderly women. Analysis of 927 cases. Crit Rev Oncol/Hematol (2008) doi:10.1016/j.critrevonc.2008.09.011.
60. Willsher P.C., Leach I.H., Ellis I.O., et al. A comparison outcome of male breast cancer with female breast cancer. Am J Surg 173 (1997) 185-188
61. Scott-Conner C.E., Jochimsen P.R., Menck H.R., and Winchester D.J. An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery 126 (1999) 775-780
62. Hill T.D., Khamis H.J., Tyczynski J.E., and Berkel H. Comparison of male and female breast cancer incidence trends, tumor characteristics and survival. Ann Epidemiol 15 (2005) 773-780
63. Anderson W.F., Althuis M.D., Brinton L.A., and Devesa S.S. Is male breast cancer similar or different than female breast cancer?. Breast Cancer Res Treat 83 (2004) 77-86
64. Speirs V., and Shaaban A.M. The rising incidence of male breast cancer. Breast Cancer Res Treat (2008)
65. Stang A., and Thomssen C. Decline in breast cancer incidence in the United States: what about male breast cancer?. Breast Cancer Res Treat (2008)
66. Contractor K.B., Kaur K., Rodrigues G.S., Kulkarni D.M., and Singhal H. Male breast cancer: is the scenario changing?. World J Surg Oncol 6 (2008) 58-69